Project Grant HT94252410719
Award Date
8/15/24
Completion Date
8/14/27
Dollars Obligated
$746K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,640,000.00 to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the brain-to-bone and bone-to-brain axis after traumatic brain injury. The 4-year award, starting on September 1, 2025, will support advanced biomedical investigations to transform healthcare for military service members, veterans, and the...
This $3,055,695 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the University of Utah's research on developing GJA1-20K as a novel treatment for hemorrhagic shock. The goal is to minimize mitochondrial injury and mitigate ischemia-reperfusion injury. This 4-year project, running from April 2024 through April 2028, will advance innovative biomedical research with potential to improve health outcomes for...
The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,314,065.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Dose-Response Relationship of Acute TBI Blood Biomarkers with Pathoanatomic Neuroimaging Findings". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...